General Information of Drug (ID: DMTN10D)

Drug Name
AR234960 Drug Info
Synonyms AR 234960; AR-234960
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
89560738
TTD Drug ID
DMTN10D

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug(s) Targeting Proto-oncogene Mas (MAS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Angiotensin-(1-7) DM76GZ0 Sarcoma 2A60-2C35 Phase 3 [2]
DSC-127 DMM0HAE Diabetic foot ulcer BD54 Phase 3 [2]
AVE 0991 DM9R3WT Discovery agent N.A. Investigative [3]
AR244555 DM68QY0 Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proto-oncogene Mas (MAS) TTOISYB MAS_HUMAN Agonist [1]

References

1 Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection. Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H299-311.
2 New therapeutic pathways in the RAS. J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):505-8.
3 Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney. Hypertension. 2004 Oct;44(4):490-6.